Trials / Unknown
UnknownNCT05146492
Pericardial Effusion From Acute Myocardial Infarction: Contributing Factors and Prognosis at One Year (EPERICARDIM)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Ramsay Générale de Santé · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to clarify, in patients with more or less abundant pericardial effusion in the acute phase of a myocardial infarction, the correlation between the existence of this effusion during the acute phase with clinical parameters, biological, angiographic, therapeutic and with transmurality, extent, microvascular obstruction and intra myocardial hemorrhage found on MRI made beyond one week and before the 3rd month of the constitution of the necrosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | MRI | MRI with gadolinium contrast media injection |
Timeline
- Start date
- 2021-07-19
- Primary completion
- 2023-01-19
- Completion
- 2024-07-19
- First posted
- 2021-12-06
- Last updated
- 2021-12-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05146492. Inclusion in this directory is not an endorsement.